欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0626/002
药品名称
Orlistato Actavis
活性成分
Orlistat 120.0 mg
剂型
Capsule, hard
上市许可持有人
Actavis Group PTC ehf.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Italy (IT)
许可日期
2012/06/18
最近更新日期
2025/01/13
药物ATC编码
A08AB01 orlistat
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
PI Orlistat 120 mg PT_H_626_01_02 Day 160 proposal CL 170412
Date of last change:2024/09/06
Final SPC
|
PI Orlistat 120 mg PT_H_626_01_02 Day 160 proposal TR 170412
Date of last change:2024/09/06
Final SPC
|
PI Orlistat 60 mg PT_H_626_01_02 Day 160 proposal CL 170412
Date of last change:2024/09/06
Final SPC
|
PI Orlistat 60 mg PT_H_626_01_02 Day 160 proposal TR 170412
Date of last change:2024/09/06
Final Product Information
|
PI_orlistat_120mg_PT_H_0626_02_270214 CL
Date of last change:2024/09/06
Final Product Information
|
PI_orlistat_60mg_PT_H_0626_01_V007_D20_131014 CL
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase